Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.

Abstract:

:Small cell lung cancer (SCLC) is an aggressive cancer characterized by several autocrine growth mechanisms including stem cell factor and its receptor c-Kit. In order to arrive at potentially new and novel therapy for SCLC, we have investigated the effects of the tyrosine kinase inhibitor, STI 571, on SCLC cell lines. It has been previously reported that STI 571 does not only inhibit cellular Abl tyrosine kinase activity but also the PDGF receptor and c-Kit tyrosine kinases at similar concentrations (approximately 0.1 microM). There is no expression of the PDGF-receptor, and the Abl kinase is not activated by SCLC, but over 70% of SCLC contain the c-Kit receptor. Utilizing this preliminary data, we have determined that three (NCI-H69, NCI-H146 and NCI-H209) of five (including NCI-H82 and NCI-H249) SCLC cell lines had detectable c-Kit receptors and were inhibited in growth and viability at concentrations 1 - 5 microM of STI 571 after 48 h of treatment. The SCLC cell lines, NCI-H69, NCI-H146 and NCI-H209, showed a dose-response (tested between 0.1 - 10 microM) inhibition of tyrosine phosphorylation of c-Kit as well as in vitro kinase activity (at 5 microM) of c-Kit in response to STI 571. STI 571 inhibited cell motility, as assessed by time-lapsed video microscopy, within 6 h of STI 571 treatment (5 microM). STI 571 also decreased intracellular levels of reactive oxygen species (ROS) by at least 60%, at a concentration (5 microM) that also inhibited cell growth. Cell cycle analysis of STI 571 responsive cells showed that cells were generally slowed in G2/M phase, but there was no arrest at G1/S. A downstream phosphorylation target of c-Kit, Akt, was not phosphorylated in response to stem cell factor in the presence of STI 571. These data imply that STI 571 inhibits growth of SCLC cells through a mechanism that involves inactivation of the tyrosine kinase c-Kit. The effectiveness of STI 571 in this study suggests this drug may be useful in a clinical trial, for patients with SCLC. Oncogene (2000) 19, 3521 - 3528

journal_name

Oncogene

journal_title

Oncogene

authors

Wang WL,Healy ME,Sattler M,Verma S,Lin J,Maulik G,Stiles CD,Griffin JD,Johnson BE,Salgia R

doi

10.1038/sj.onc.1203698

subject

Has Abstract

pub_date

2000-07-20 00:00:00

pages

3521-8

issue

31

eissn

0950-9232

issn

1476-5594

journal_volume

19

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.

    abstract::MicroRNAs (miRNAs) are small non-coding RNAs involved in the regulation of critical cell processes such as apoptosis, cell proliferation and differentiation. A small set of miRNAs is differentially expressed in hematopoietic cells and seemingly has an important role in granulopoiesis and lineage differentiation. In th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.255

    authors: Careccia S,Mainardi S,Pelosi A,Gurtner A,Diverio D,Riccioni R,Testa U,Pelosi E,Piaggio G,Sacchi A,Lavorgna S,Lo-Coco F,Blandino G,Levrero M,Rizzo MG

    更新日期:2009-11-12 00:00:00

  • ELAS1-mediated inhibition of the cyclin G1-B'γ interaction promotes cancer cell apoptosis via stabilization and activation of p53.

    abstract::Radiation therapy (RT) is useful for selectively killing cancer cells. However, because high levels of ionizing radiation (IR) are toxic to normal cells, RT cannot be applied repeatedly to cancer patients. Therefore, novel chemicals that enhance the efficacy of chemoradiotherapy (CRT) would be valuable. Here, we repor...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.47

    authors: Ohno S,Naito Y,Mukai S,Yabuta N,Nojima H

    更新日期:2015-12-03 00:00:00

  • Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins.

    abstract::An early event of cell migration is characterized as the rapid reorganization of the actin cytoskeleton. Recently, we have demonstrated that rapamycin inhibits tumor cell motility. To understand the underlying mechanism, this study was set to determine whether rapamycin inhibition of cell motility is related to its pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.137

    authors: Liu L,Chen L,Chung J,Huang S

    更新日期:2008-08-28 00:00:00

  • Inhibition of CD4/p56lck signaling by a dominant negative mutant of the Shc adaptor protein.

    abstract::T-cell antigen receptor stimulation results in phosphorylation of the SH2 containing Shc proteins and recruitment of the Grb2/mSos complex suggesting that Shc proteins are involved in transducing T-cell activating signals to Ras. We have measured the effects of the isolated Shc-SH2 domain and the dominant negative Ras...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Baldari CT,Pelicci G,Di Somma MM,Milia E,Giuli S,Pelicci PG,Telford JL

    更新日期:1995-03-16 00:00:00

  • Translin binds to the sequences adjacent to the breakpoints of the TLS and CHOP genes in liposarcomas with translocation t(12;6).

    abstract::Myxoid and round-cell liposarcomas share the translocation t(12;16)(q13;p11) creating the TLS-CHOP fusion gene as a common genetic alteration. We previously reported several unique characteristics of genomic sequences around the breakpoints in the TLS and CHOP loci, and among them was the presence of consensus recogni...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203943

    authors: Hosaka T,Kanoe H,Nakayama T,Murakami H,Yamamoto H,Nakamata T,Tsuboyama T,Oka M,Kasai M,Sasaki MS,Nakamura T,Toguchida J

    更新日期:2000-11-23 00:00:00

  • Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B.

    abstract::SEMA3B, a member of class 3 semaphorins, is a tumor suppressor. Competition with vascular endothelial growth factor (VEGF)165 explains a portion of the activity, whereas the VEGF-independent mechanism was not elucidated. We employed a microarray and screened for the genes whose expression was increased by SEMA3B in NC...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.263

    authors: Koyama N,Zhang J,Huqun,Miyazawa H,Tanaka T,Su X,Hagiwara K

    更新日期:2008-11-20 00:00:00

  • Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells.

    abstract::The role of cyclooxygenase-2 (COX-2) in cancer remains controversial. Using cervical carcinoma cells (HeLa), the present study investigates the involvement of COX-2 in apoptosis elicited by the chemotherapeutics paclitaxel, cisplatin and 5-fluorouracil. Each compound led to a profound induction of COX-2 expression and...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210962

    authors: Eichele K,Ramer R,Hinz B

    更新日期:2008-05-08 00:00:00

  • The amino-terminus of the E2F-1 transcription factor inhibits DNA replication of autonomously replicating plasmids in mammalian cells.

    abstract::The E2F1 transcription factor plays a pivotal role in driving cells out of a quiescent state and into the S phase of the cell cycle, in part by transactivating genes needed for DNA replication including DHFR, thymidine kinase, and DNA Polymerase alpha. E2F1 has also been implicated in regulating an S phase checkpoint,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205473

    authors: Stubbs MC,Hall DJ

    更新日期:2002-05-23 00:00:00

  • The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer.

    abstract::Beta-transducin repeats-containing proteins (beta-TrCP) serve as the substrate recognition subunits for the SCFbeta-TrCP E3 ubiquitin ligases. These ligases ubiquitinate specifically phosphorylated substrates and play a pivotal role in the regulation of cell division and various signal transduction pathways, which, in...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1207389

    authors: Fuchs SY,Spiegelman VS,Kumar KG

    更新日期:2004-03-15 00:00:00

  • Human T-cell leukemia virus type 1 Tax protein induces the expression of STAT1 and STAT5 genes in T-cells.

    abstract::Human T-cell leukemia virus type 1 (HTLV-1) Tax transforms normal T-cells in the presence of interleukin (IL)-2 in vitro. STAT is a family of transcription factors that play a pivotal role in cytokine-induced functions of a various type of cells. We investigated the involvement of STATs in the transformation of T-cell...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202608

    authors: Nakamura N,Fujii M,Tsukahara T,Arai M,Ohashi T,Wakao H,Kannagi M,Yamamoto N

    更新日期:1999-04-29 00:00:00

  • Activation of oncogenes in human oral cancer cells: a novel codon 13 mutation of c-H-ras-1 and concurrent amplifications of c-erbB-1 and c-myc.

    abstract::By NIH3T3 transfection assay in conjunction with in vitro transient neomycin selection, activated c-H-ras-1 oncogenes were detected in two squamous cell carcinoma cell lines, ZA and HOC-313, newly established from human oral cancer patients. ZA had a point mutational activation at the 13th codon, this activation of c-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Tadokoro K,Ueda M,Ohshima T,Fujita K,Rikimaru K,Takahashi N,Enomoto S,Tsuchida N

    更新日期:1989-04-01 00:00:00

  • Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.

    abstract::Cyclin D1, a putative G1 cyclin, has been implicated in cell cycle control. The human cyclin D1 gene is located on chromosome 11q13 where DNA rearrangement and amplification have been detected in several types of human cancer. Previous studies demonstrated that the cyclin D1 gene is not only rearranged or amplified bu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Jiang W,Kahn SM,Zhou P,Zhang YJ,Cacace AM,Infante AS,Doi S,Santella RM,Weinstein IB

    更新日期:1993-12-01 00:00:00

  • Mutations of TP53 induce loss of DNA methylation and amplification of the TROP1 gene.

    abstract::p53 and DNA methylation play key roles in the maintenance of genome stability. In this work, we demonstrate that the two mechanisms are linked and that p53 plays a role in the maintenance of the DNA methylation levels. The loss of p53 was shown to induce loss of DNA methylation in the TROP1 gene, a human cancer-expres...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206248

    authors: Nasr AF,Nutini M,Palombo B,Guerra E,Alberti S

    更新日期:2003-03-20 00:00:00

  • KRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties.

    abstract::Studies have reported that interactions between keratins (KRTs) and other proteins initiate signaling cascades that regulate cell migration, invasion, and metastasis. In the current study, we found that expression of KRT19 was specifically high in breast cancers and significantly correlated with their invasiveness. Mo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.221

    authors: Saha SK,Choi HY,Kim BW,Dayem AA,Yang GM,Kim KS,Yin YF,Cho SG

    更新日期:2017-01-19 00:00:00

  • B-Raf protein isoforms interact with and phosphorylate Mek-1 on serine residues 218 and 222.

    abstract::The B-raf/c-Rmil proto-oncogene belongs to the raf/mil family of serine/threonine protein kinases. It encodes multiple protein isoforms resulting from alternative splicing of two exons located upstream of the kinase domain. Recent studies suggested that B-Raf could be the intermediate molecule between Ras and Mek-1 (M...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Papin C,Eychène A,Brunet A,Pagès G,Pouysségur J,Calothy G,Barnier JV

    更新日期:1995-04-20 00:00:00

  • Vimentin is a novel AKT1 target mediating motility and invasion.

    abstract::The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.421

    authors: Zhu QS,Rosenblatt K,Huang KL,Lahat G,Brobey R,Bolshakov S,Nguyen T,Ding Z,Belousov R,Bill K,Luo X,Lazar A,Dicker A,Mills GB,Hung MC,Lev D

    更新日期:2011-01-27 00:00:00

  • Human T-cell leukemia virus type I and adult T-cell leukemia.

    abstract::Human T-cell leukemia virus type I (HTLV-I) causes adult T-cell leukemia (ATL) in about 5% of carriers after a long latent period. After its infection, HTLV-I promotes the clonal proliferation of HTLV-I infected cells in vivo by actions of encoded viral proteins, including Tax. However, leukemic cells frequently lack ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206551

    authors: Matsuoka M

    更新日期:2003-08-11 00:00:00

  • Epigenetic regulations in hematopoietic Hox code.

    abstract::Hox genes encode DNA-binding proteins that are deployed in overlapping domains along various body axes during embryonic development. This sequential activation of Hox genes in temporal and spatial mode, the Hox code, is critical for the proper positioning of segmented structures along those axes, which include the ver...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.484

    authors: He H,Hua X,Yan J

    更新日期:2011-01-27 00:00:00

  • Isolation of HELAD1, a novel human helicase gene up-regulated in colorectal carcinomas.

    abstract::To investigate the mechanisms of colorectal carcinogenesis, we searched for genes regulated by adenomatous polyposis coli gene product (APC) and identified a novel gene, termed HELAD1 (helicase, APC down-regulated 1). A recombinant polypeptide representing the ATPases associated with cellular activities (AAA) domain o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205751

    authors: Ishiguro H,Shimokawa T,Tsunoda T,Tanaka T,Fujii Y,Nakamura Y,Furukawa Y

    更新日期:2002-09-12 00:00:00

  • p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia.

    abstract::The retinoblastoma gene product (pRb) controls proliferation and differentiation processes in stratified epithelia. Importantly, and in contrast to other tissues, Rb deficiency does not lead to spontaneous skin tumor formation. As the cyclin-dependent kinase inhibitor p21 regulates proliferation and differentiation in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.417

    authors: Saiz-Ladera C,Lara MF,Garín M,Ruiz S,Santos M,Lorz C,García-Escudero R,Martínez-Fernández M,Bravo A,Fernández-Capetillo O,Segrelles C,Paramio JM

    更新日期:2014-09-11 00:00:00

  • Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.

    abstract::Chromosomal aberrations are a hallmark of human cancers, with complex cytogenetic rearrangements leading to genetic changes permissive for cancer initiation and progression. Protection of Telomere 1 (POT1) is an essential component of the shelterin complex and functions to maintain chromosome stability by repressing t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.405

    authors: Gu P,Wang Y,Bisht KK,Wu L,Kukova L,Smith EM,Xiao Y,Bailey SM,Lei M,Nandakumar J,Chang S

    更新日期:2017-04-06 00:00:00

  • Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis.

    abstract::VEGFR-1 (Flt-1), VEGFR-2 (KDR) and VEGFR-3 (Flt4) are endothelial specific receptor tyrosine kinases, regulated by members of the vascular endothelial growth factor family. VEGFRs are indispensable for embryonic vascular development, and are involved in the regulation of many aspects of physiological and pathological ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1203855

    authors: Karkkainen MJ,Petrova TV

    更新日期:2000-11-20 00:00:00

  • Function for p300 and not CBP in the apoptotic response to DNA damage.

    abstract::The cellular response to ionizing radiation (IR) includes the induction of apoptosis. The p300/CBP proteins possess histone acetyltransferase activity and function as transcriptional coactivators of p53. We have prepared cells deficient in p300 or CBP to define the roles of these proteins in the cellular response to D...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202930

    authors: Yuan ZM,Huang Y,Ishiko T,Nakada S,Utsugisawa T,Shioya H,Utsugisawa Y,Shi Y,Weichselbaum R,Kufe D

    更新日期:1999-10-07 00:00:00

  • Chimeric c-Jun containing an heterologous homodimerization domain transforms primary chick embryo fibroblasts.

    abstract::To investigate a possible role for c-Jun homodimers in c-Jun-mediated transformation, we designed two chimeric c-Jun derivatives, called c-Juneb1 and c-Jungcn4. In these chimeric derivatives the natural dimerization domain of c-Jun was replaced by the heterologous homodimerization domain of the Epstein-Barr virus EB1 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Castellazzi M,Loiseau L,Piu F,Sergeant A

    更新日期:1993-05-01 00:00:00

  • The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin.

    abstract::Ubiquitin-conjugation targets numerous cellular regulators for proteasome-mediated degradation. Thus, the identification of ubiquitin ligases and their physiological substrates is crucially important, especially for those cases in which aberrant levels of regulatory proteins (e.g., beta-catenin, p27) result from a der...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202653

    authors: Latres E,Chiaur DS,Pagano M

    更新日期:1999-01-28 00:00:00

  • Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors.

    abstract::SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling. Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1211019

    authors: Miyamoto D,Miyamoto M,Takahashi A,Yomogita Y,Higashi H,Kondo S,Hatakeyama M

    更新日期:2008-06-05 00:00:00

  • The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor.

    abstract::The mixed lineage leukemia (MLL) gene at chromosome band 11q23 is commonly involved in reciprocal translocations that are detected in acute leukemias. Evidence suggests that the resulting MLL fusion genes contribute to leukemogenesis. AF9 is a common MLL fusion partner in acute myeloid leukemia. The AF9 protein functi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206361

    authors: Srinivasan RS,de Erkenez AC,Hemenway CS

    更新日期:2003-05-29 00:00:00

  • Enhanced EGF mitogenic response is associated with enhanced tyrosine phosphorylation of specific cellular proteins in fibroblasts overexpressing c-src.

    abstract::In previous studies examining the role of pp60c-src in cellular proliferation, we demonstrated that overexpression of wild type (wt) but not mutated c-src in C3H10T1/2 murine embryo fibroblasts resulted in a 2 to 5 fold enhancement of DNA synthesis in response to epidermal growth factor (EGF). Using phosphotyrosine an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wilson LK,Parsons SJ

    更新日期:1990-10-01 00:00:00

  • Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light.

    abstract::The tumor suppressor protein, p53, plays a critical role as a transcriptional activator of downstream target genes involved in the cellular response to DNA damaging agents. We examined the cell cycle checkpoint response of human mammary epithelial cells (HMEC) and their isogenic fibroblast counterparts to ionizing (IR...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202977

    authors: Meyer KM,Hess SM,Tlsty TD,Leadon SA

    更新日期:1999-10-14 00:00:00

  • BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains.

    abstract::Germ-line alterations in BRCA1 are associated with an increased susceptibility to breast and ovarian cancer. BRCA1 is a 220-kDa protein that contains a tandem of two BRCA1 C-Terminal (BRCT) domains. Among missense and nonsense BRCA1 mutations responsible for family breast cancer, some are located into the BRCT tandem ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205915

    authors: Magnard C,Bachelier R,Vincent A,Jaquinod M,Kieffer S,Lenoir GM,Venezia ND

    更新日期:2002-10-03 00:00:00